series-a
Stage
2020
Founded
1
Investors
About
Developer of inhaled therapeutics designed to treat severe pulmonary diseases. The company's therapeutics focuses on diseases including pulmonary hypertension and cystic fibrosis, providing patients with targeted therapies to enhance the quality of life.
Explore Aer Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.